Direct Thrombus Imaging in Stroke

다국어 초록 (Multilingual Abstract)

There is an emergent need for imaging methods to better triage patients with acute stroke for tissue-plasminogen activator (tPA)-mediated thrombolysis or endovascular clot retrieval by directly visualizing the size and distribution of cerebral thromboemboli. Currently, magnetic resonance (MR) or computed tomography (CT) angiography visualizes the obstruction of blood flow within the vessel lumen rather than the thrombus itself. The present visualization method, which relies on observation of the dense artery sign (the appearance of cerebral thrombi on a non-enhanced CT), suffers from low sensitivity. When translated into the clinical setting, direct thrombus imaging is likely to enable individualized acute stroke therapy by allowing clinicians to detect the thrombus with high sensitivity, assess the size and nature of the thrombus more precisely, serially monitor the therapeutic effects of thrombolysis, and detect post-treatment recurrence. This review is intended to provide recent updates on stroke-related direct thrombus imaging using MR imaging, positron emission tomography, or CT

참고문헌 (Reference)

1 이동근, "Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?" 대한신경과학회 6 (6): 10-18, 2010

2 Virmani R, "Vulnerable plaque : the pathology of unstable coronary lesions" 15 : 439-446, 2002

3 Gravanis I, "Tissue-type plasminogen activator as a therapeutic target in stroke" 12 : 159-170, 2008

4 Adibhatla RM, "Tissue plasminogen activator(tPA)and matrix metalloproteinases in the pathogenesis of stroke : therapeutic strategies" 7 : 243-253, 2008

5 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, "Tissue plasminogen activator for acute ischemic stroke" 333 : 1581-1587, 1995

6 Weisstanner C, "Thrombus imaging in acute stroke : correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success" 24 : 1735-1741, 2014

7 Nighoghossian N, "The vulnerable carotid artery plaque : current imaging methods and new perspectives" 36 : 2764-2772, 2005

8 Bunevicius A, "The potential roles of 18F-FDG-PET in management of acute stroke patients" 2013 : 634598-, 2013

9 Ahn SG, "The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction" 26 : 245-253, 2015

10 Walter J, "Textbook of Interventional Cardiovascular Pharmacology: Chapter 1 An overview of hemostasis and thrombosis" CRC Press 1-29, 2007

11 Anderson NG, "Spectroscopic(multi-energy)CT distinguishes iodine and barium contrast material in MICE" 20 : 2126-2134, 2010

12 Wen AM, "Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging" 3 : 6037-6045, 2015

13 Kramer MC, "Relationship of thrombus healing to underlying plaque morphology in sudden coronary death" 55 : 122-132, 2010

14 Chueh JY, "Reduction in distal emboli with proximal flow control during mechanical thrombectomy : a quantitative in vitro study" 44 : 1396-1401, 2013

15 Grover SP, "Quantification of experimental venous thrombus resolution by longitudinal nanogold-enhanced micro-computed tomography" 136 : 1285-1290, 2015

16 Kim DE, "Primer on cerebrovascular diseases" Elsevier/Academic Press

17 Aouad P, "Prevalence, Comorbid Associations and Prognostic Value of the Hyperdense Middle Cerebral Artery Sign" 2013 : 6-, 2013

18 Young L, "Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality" 4 : 1919-1924, 2006

19 Patel R, "Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography" 31 : 2007-2014, 2011

20 Jha B, "Pearls & oy-sters: hyperdense or pseudohyperdense MCA sign: a Damocles sword?" 72 : e116-e117, 2009

21 Applegate RJ, "Optimal therapy for ST-segment elevation myocardial infarction : the role of residual thrombus" 57 : 1874-1876, 2011

22 Flacke S, "Novel MRI contrast agent for molecular imaging of fibrin : implications for detecting vulnerable plaques" 104 : 1280-1285, 2001

23 Lindner JR, "Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes" 102 : 2745-2750, 2000

24 Aziz K, "Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography" 117 : 2061-2070, 2008

25 Kearon C, "Natural history of venous thromboembolism" 107 : 122-130, 2003

26 Stern ST, "Nanotechnology safety concerns revisited" 101 : 4-21, 2008

27 Xie J, "Nanoparticle-based theranostic agents" 62 : 1064-1079, 2010

28 Song HK, "Multislice double inversion pulse sequence for efficient black-blood MRI" 47 : 616-620, 2002

29 Blasi F, "Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats" 35 : 2114-2121, 2015

30 Uppal R, "Molecular MRI of intracranial thrombus in a rat ischemic stroke model" 41 : 1271-1277, 2010

31 Heidt T, "Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging" 6 : 25044-, 2016

32 Klink A, "Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe" 30 : 403-410, 2010

33 von zur Muhlen C, "Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis" 118 : 258-267, 2008

34 Viereck J, "MRI of atherothrombosis associated with plaque rupture" 25 : 240-245, 2005

35 Gobin YP, "MERCI 1 : a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia" 35 : 2848-2854, 2004

36 Anderson CS, "Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke" 374 : 2313-2323, 2016

37 Corti R, "In vivo noninvasive detection and age definition of arterial thrombus by MRI" 39 : 1366-1373, 2002

38 Ay I, "In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe" 7 : 697-705, 2014

39 Botnar RM, "In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent" 109 : 2023-2029, 2004

40 Johnstone MT, "In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model" 21 : 1556-1560, 2001

41 Kim DE, "Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles" 73 : 617-625, 2013

42 Mozaffarian D, "Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association" 133 : e38-e360, 2016

43 Ciesienski KL, "Fibrin-targeted PET probes for the detection of thrombi" 10 : 1100-1110, 2013

44 Edelman RR, "Fast selective black blood MR imaging" 181 : 655-660, 1991

45 Blasi F, "Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes" 55 : 1157-1163, 2014

46 Overoye-Chan K, "EP-2104R : a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus" 130 : 6025-6039, 2008

47 von Elverfeldt D, "Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging" 130 : 676-687, 2014

48 Kim DE, "Direct thrombus imaging as a means to control the variability of mouse embolic infarct models : the role of optical molecular imaging" 42 : 3566-3573, 2011

49 Kim JY, "Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles" 5 : 1098-1114, 2015

50 Guerrero WR, "Defining intravenous recombinant tissue plasminogen activator failure" 44 : 819-821, 2013

51 Burke AP, "Coronary risk factors and plaque morphology in men with coronary disease who died suddenly" 336 : 1276-1282, 1997

52 Yuan C, "Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization" 15 : 62-67, 2002

53 Jaberi A, "Computed tomography angiography intraluminal filling defect is predictive of internal carotid artery free-floating thrombus" 56 : 15-23, 2014

54 Glagov S, "Compensatory enlargement of human atherosclerotic coronary arteries" 316 : 1371-1375, 1987

55 Kim DE, "Combined near-infrared fluorescent imaging and micro-computed tomography for directly visualizing cerebral thromboemboli"

56 Sirol M, "Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent" 112 : 1594-1600, 2005

57 Moody AR, "Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia" 107 : 3047-3052, 2003

58 Mamlouk MD, "Cerebral thromboembolism : value of susceptibility-weighted imaging in the initial diagnosis of acute infarction" 25 : 45-56, 2012

59 JM UK-I, "Carotid-artery imaging in the diagnosis and management of patients at risk of stroke" 8 : 569-580, 2009

60 Liebeskind DS, "CT and MRI early vessel signs reflect clot composition in acute stroke" 42 : 1237-1243, 2011

61 Crouse JR, 3rd, "Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery" 92 : 1141-1147, 1995

62 Kirmani JF, "Advances in thrombolytics for treatment of acute ischemic stroke" 79 : S119-S125, 2012

63 Weinberger J, "A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography : an initial report" 29 : 673-676, 1998

64 Gale EM, "A Manganese Alternative to Gadolinium for MRI Contrast" 137 : 15548-15557, 2015

65 Hara T, "18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus" 130 : 1044-1052, 2014